Press

Press

Coverage of Q-Gen Bio and our parent institute, KIQBNS.

NewswireSep 7, 2026

Non-invasive electroceutical technology confirms neurovascular/autonomic synchrony, laying groundwork for glymphatic research

Reports that KIQBNS and Q-Gen Bio jointly presented research on inducing wake-state K-complex-like responses at K-Brain 2026, observing that cerebral blood flow and heart-rate variability move together in the roughly 0.1 Hz Mayer-wave band, and that a related international patent (PCT) received a favorable search report from the international searching authority. (Original article in Korean)

Read original ↗
Women TimesSep 7, 2026

Brainwaves, heart, and blood flow moving to the same beat

An interview piece on Q-Gen Bio CEO Kim Kwang-woo's presentation on K-complex/Mayer-wave synchrony at K-Brain 2026, covering how this year's work documents how that waveform relates to heart and blood-flow rhythms, following last year's presentation on inducing wake-state K-complex activity. (Original article in Korean)

Read original ↗
NewswireApr 20, 2026

KIQBNS presents research on clearing brain waste products in the waking state

Covers founder Kim Kwang-woo's presentation at the Stanford AKN Symposium on tRFPM-based brain waste clearance research, proposing a mechanism to physically mitigate ARIA, a side effect of antibody-based dementia treatments. (Original article in Korean)

Read original ↗
Women TimesAug 28, 2025

A 70-year-old researcher makes his debut in the scientific establishment through a poster session

Covers the story of independent researcher Kim Kwang-woo, who spent 40 years studying the K-complex on his own, presenting his first poster at K-Brain 2025 and entering the formal scientific community, with KAIST graduate Dr. Kim Gil-hyun mentoring him on scientific validation methodology. (Original article in Korean)

Read original ↗

Founder Kim Kwang-woo

You can find the founder's research background and network on LinkedIn.

LinkedIn profile ↗